V&N MedLaser

M22 XPL (Advanced IPL) Total Skin Renewal

At V&N MedLaser Aesthetic Studio, we use M22 XPL (Advanced IPL) Total Skin Renewal to treat multiple skin concerns in one comprehensive procedure. This treatment is designed for clients who want visible improvement in redness, pigmentation, vascular issues and overall skin quality without aggressive downtime.

M22 XPL (Advanced IPL) Total Skin Renewal Treatment

Benefits of Total Skin Renewal

Targets pigmentation, sun damage and uneven tone

Reduces rosacea, redness and visible capillaries

Treats spider veins and vascular lesions

Softens fine lines and smooths the skin surface

Improves pore appearance and skin texture

Stimulates collagen for firmer, healthier looking skin

Why Choose V&N MedLaser for Total Skin Renewal

Using specialized filters and controlled high intensity light energy, M22 XPL (Advanced IPL) works at different depths of the skin to simultaneously target excess melanin and dilated blood vessels.

Light energy selectively absorbed by pigment and hemoglobin

Helps fade discoloration and calm vascular redness

Restores a clearer, more even complexion

Gentle thermal stimulation supports collagen remodeling

Improves skin firmness, elasticity and smoothness

The result is brighter, calmer and more refined skin that feels smoother and looks healthier. Many clients notice visible improvement after the first session, with continued enhancement over a recommended course of treatments.

Frequently Asked Questions

We recommend 1–3 sessions depending on the skin condition, with maintenance once a year.

M22 XPL (Advanced IPL) Total Skin Renewal can address pigmentation, sun damage, uneven tone, rosacea, redness, visible capillaries, spider veins, vascular lesions, fine lines, pore appearance, and overall skin texture.

Many clients notice visible improvement after the first session, with continued enhancement over a recommended course of treatments.

Ready to Get Started?

Book your free consultation today and discover comprehensive skin renewal.